• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Stroke Cerebrovasc Dis . Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex

tetano

Editor, Senior Moderator
J Stroke Cerebrovasc Dis


. 2020 Sep 11;105314.
doi: 10.1016/j.jstrokecerebrovasdis.2020.105314. Online ahead of print.
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex


G Trifan[SUP] 1 [/SUP], F D Goldenberg[SUP] 2 [/SUP], F C Caprio[SUP] 3 [/SUP], J Biller[SUP] 4 [/SUP], M Schneck[SUP] 5 [/SUP], A Khaja[SUP] 6 [/SUP], T Terna[SUP] 7 [/SUP], J Brorson[SUP] 8 [/SUP], C Lazaridis[SUP] 9 [/SUP], Z Bulwa[SUP] 10 [/SUP], R Alvarado Dyer[SUP] 11 [/SUP], F G Saleh Velez[SUP] 12 [/SUP], S Prabhakaran[SUP] 13 [/SUP], E M Liotta[SUP] 14 [/SUP], A Batra[SUP] 15 [/SUP], N J Reish[SUP] 16 [/SUP], S Ruland[SUP] 17 [/SUP], M Teitcher[SUP] 18 [/SUP], W Taylor[SUP] 19 [/SUP], P De la Pena[SUP] 20 [/SUP], J J Conners[SUP] 21 [/SUP], P K Grewal[SUP] 22 [/SUP], P Pinna[SUP] 23 [/SUP], R M Dafer[SUP] 24 [/SUP], N D Osteraas[SUP] 25 [/SUP], I DaSilva[SUP] 26 [/SUP], J P Hall[SUP] 27 [/SUP], S John[SUP] 28 [/SUP], N Shafi[SUP] 29 [/SUP], K Miller[SUP] 30 [/SUP], B Moustafa[SUP] 31 [/SUP], A Vargas[SUP] 32 [/SUP], P B Gorelick[SUP] 33 [/SUP], F D Testai[SUP] 34 [/SUP]



Affiliations

Abstract

Background and purpose: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is associated with stroke. The role of sex on stroke outcome has not been investigated. To objective of this paper is to describe the characteristics of a diverse cohort of acute stroke patients with COVID-19 disease and determine the role of sex on outcome.
Methods: This is a retrospective study of patients with acute stroke and SARS-CoV-2 infection admitted between March 15 to May 15, 2020 to one of the six participating comprehensive stroke centers. Baseline characteristics, stroke subtype, workup, treatment and outcome are presented as total number and percentage or median and interquartile range. Outcome at discharge was determined by the modified Rankin Scale Score (mRS). Variables and outcomes were compared for males and females using univariate and multivariate analysis.
Results: The study included 83 patients, 47% of which were Black, 28% Hispanics/Latinos, and 16% whites. Median age was 64 years. Approximately 89% had at least one preexisting vascular risk factor (VRF). The most common complications were respiratory failure (59%) and septic shock (34%). Compared with females, a higher proportion of males experienced severe SARS-CoV-2 symptoms requiring ICU hospitalization (73% vs. 49%; p = 0.04). When divided by stroke subtype, there were 77% ischemic, 19% intracerebral hemorrhage and 3% subarachnoid hemorrhage. The most common ischemic stroke etiologies were cryptogenic (39%) and cardioembolic (27%). Compared with females, males had higher mortality (38% vs. 13%; p = 0.02) and were less likely to be discharged home (12% vs. 33%; p = 0.04). After adjustment for age, race/ethnicity, and number of VRFs, mRS was higher in males than in females (OR = 1.47, 95% CI = 1.03-2.09).
Conclusion: In this cohort of SARS-CoV-2 stroke patients, most had clinical evidence of coronavirus infection on admission and preexisting VRFs. Severe in-hospital complications and worse outcomes after ischemic strokes were higher in males, than females.

Keywords: COVID-19; Outcome; Race; Sex; Stroke.
 
Back
Top Bottom